GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Notes Receivable

G.Barekat Pharm (XTEH:BRKT1) Notes Receivable : IRR0 Mil (As of Mar. 2017)


View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Notes Receivable?

G.Barekat Pharm's Notes Receivable for the quarter that ended in Mar. 2017 was IRR0 Mil.


G.Barekat Pharm Notes Receivable Historical Data

The historical data trend for G.Barekat Pharm's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Notes Receivable Chart

G.Barekat Pharm Annual Data
Trend Mar16 Mar17
Notes Receivable
- -

G.Barekat Pharm Semi-Annual Data
Mar16 Mar17
Notes Receivable - -

G.Barekat Pharm Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


G.Barekat Pharm Notes Receivable Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


G.Barekat Pharm (XTEH:BRKT1) Business Description

Traded in Other Exchanges
N/A
Address
No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN
G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines